Annual Total Long Term Liabilities
$2.22 B
+$477.48 M+27.36%
December 31, 2024
Summary
- As of March 12, 2025, BBIO annual total long term liabilities is $2.22 billion, with the most recent change of +$477.48 million (+27.36%) on December 31, 2024.
- During the last 3 years, BBIO annual total long term liabilities has risen by +$479.25 million (+27.49%).
- BBIO annual total long term liabilities is now at all-time high.
Performance
BBIO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.22 B
+$478.40 M+27.43%
December 31, 2024
Summary
- As of March 12, 2025, BBIO quarterly total long term liabilities is $2.22 billion, with the most recent change of +$478.40 million (+27.43%) on December 31, 2024.
- Over the past year, BBIO quarterly long term liabilities has increased by +$478.40 million (+27.43%).
- BBIO quarterly long term liabilities is now at all-time high.
Performance
BBIO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
BBIO Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.4% | +27.4% |
| 3 y3 years | +27.5% | +27.4% |
| 5 y5 years | +2231.7% | +27.4% |
BBIO Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +27.5% | at high | +28.0% |
| 5 y | 5-year | at high | +2231.7% | at high | +2231.7% |
| alltime | all time | at high | +3940.8% | at high | +3940.8% |
BridgeBio Pharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.22 B(+27.4%) | $2.22 B(+27.4%) |
| Sep 2024 | - | $1.74 B(+0.1%) |
| Jun 2024 | - | $1.74 B(-0.1%) |
| Mar 2024 | - | $1.74 B(-0.0%) |
| Dec 2023 | $1.75 B(-0.1%) | $1.75 B(+0.1%) |
| Sep 2023 | - | $1.74 B(-0.0%) |
| Jun 2023 | - | $1.74 B(+0.0%) |
| Mar 2023 | - | $1.74 B(-0.2%) |
| Dec 2022 | $1.75 B(+0.2%) | $1.75 B(+0.4%) |
| Sep 2022 | - | $1.74 B(+0.2%) |
| Jun 2022 | - | $1.74 B(-0.8%) |
| Mar 2022 | - | $1.75 B(+0.4%) |
| Dec 2021 | $1.74 B | $1.74 B(+22.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $1.42 B(+1.2%) |
| Jun 2021 | - | $1.41 B(+1.3%) |
| Mar 2021 | - | $1.39 B(+177.3%) |
| Dec 2020 | $500.05 M(+424.6%) | $500.05 M(+1.3%) |
| Sep 2020 | - | $493.60 M(+1.8%) |
| Jun 2020 | - | $485.07 M(+2.6%) |
| Mar 2020 | - | $472.81 M(+396.0%) |
| Dec 2019 | $95.32 M(+73.3%) | $95.32 M(+24.8%) |
| Sep 2019 | - | $76.41 M(-86.2%) |
| Jun 2019 | - | $554.39 M(+903.6%) |
| Mar 2019 | - | $55.24 M(+0.4%) |
| Dec 2018 | $55.00 M(-61.9%) | $55.00 M |
| Dec 2017 | $144.18 M | - |
FAQ
- What is BridgeBio Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for BridgeBio Pharma?
- What is BridgeBio Pharma annual total long term liabilities year-on-year change?
- What is BridgeBio Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly long term liabilities year-on-year change?
What is BridgeBio Pharma annual total long term liabilities?
The current annual total long term liabilities of BBIO is $2.22 B
What is the all time high annual total long term liabilities for BridgeBio Pharma?
BridgeBio Pharma all-time high annual total long term liabilities is $2.22 B
What is BridgeBio Pharma annual total long term liabilities year-on-year change?
Over the past year, BBIO annual total long term liabilities has changed by +$477.48 M (+27.36%)
What is BridgeBio Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of BBIO is $2.22 B
What is the all time high quarterly long term liabilities for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly total long term liabilities is $2.22 B
What is BridgeBio Pharma quarterly long term liabilities year-on-year change?
Over the past year, BBIO quarterly total long term liabilities has changed by +$478.40 M (+27.43%)